Abstract:Abstract Lung adenocarcinoma (LuAD) is the most prevalent subtype of lung cancer but despite advances in targeted therapy approaches, LuAD patients still have a 5-year survival rate of less than 15%. This is largely owed to a high variability in cancer driver mutations, with only around 25% of patients being eligible for targeted therapy, highlighting the need for therapy approaches beyond the level of genetic modifications. In order to determine novel vulnerabilities of LuAD, we performed a CRISPR/Cas9-based genomic screen with a pooled sgRNA library targeting genes of the ubiquitin system. The screen identified the poorly characterized E3-ubiquitin ligase DCAF13 as an essential gene for LuAD cell survival. Data mining of LuAD patient data revealed that DCAF13 is significantly overexpressed in tumor versus normal tissue and that high DCAF13 expression correlates with adverse overall survival and progression free survival. Mechanistically, DCAF13 depletion leads to a decrease in cell proliferation and subsequent cell death, which can be rescued by apoptosis inhibition. Immunofluorescence revealed that DCAF13 localizes to the centrosome, cell-cell contacts and the nucleus of LuAD cells, indicating a potential role in transcription control. Functionally, DCAF13 is a predicted substrate recruiting unit of a CUL4-family ubiquitin ligase. Indeed, we show that DCAF13 binds to CUL4B and DDB1 to form an active ubiquitin ligase complex. In an effort to identify lung cancer specific relevant ubiquitylation substrates of DCAF13, we performed affinity-based interactome screens and non-affinity-based functional proteomics in LuAD cells. Cross-validation of these approaches revealed distinct tumor-suppressive transcription factors, which are known to play a role in tumorigenesis, embryogenesis and stem cell differentiation. Ongoing biochemical and transcriptomic analyses further determine the involvement of these transcription factors and DCAF13 in the establishment and maintenance of LuAD. Taken together, we nominate DCAF13 as a novel vulnerability in LuAD with potential implication in future targeted therapy strategies. Citation Format: Vinona T. Wagner, Yun-Chien Chang, Piero Giansanti, Rupert Öllinger, Thomas Engleitner, Bernhard Kuster, Florian Bassermann. A multi-omic screening approach identifies the E3-ubiquitin ligase DCAF13 as a novel vulnerability in lung adenocarcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 2575.

DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma

The E3 Ligase Ring1 Targets P53 For Degradation And Promotes Cancer Cell Proliferation And Survival

Increased Cul1 Expression Promotes Melanoma Cell Proliferation Through Regulating P27 Expression

DCAF13 promotes breast cancer cell proliferation by ubiquitin inhibiting PERP expression

Abstract 2575: A multi-omic screening approach identifies the E3-ubiquitin ligase DCAF13 as a novel vulnerability in lung adenocarcinoma

DCAF4L2 Promotes Colorectal Cancer Invasion and Metastasis Via Mediating Degradation of NFκb Negative Regulator PPM1B.

DCAF13 promotes ovarian cancer progression by activating FRAS1-mediated FAK signaling pathway

RNF115-mediated ubiquitination of p53 regulates lung adenocarcinoma proliferation

DDX18 Facilitates the Tumorigenesis of Lung Adenocarcinoma by Promoting Cell Cycle Progression through the Upregulation of CDK4

CRL2KLHDC3 mediates p14ARF N-terminal ubiquitylation degradation to promote non-small cell lung carcinoma progression

FAM111B, a direct target of p53, promotes the malignant process of lung adenocarcinoma.

EIF3H Interacts with PDCD4 Enhancing Lung Adenocarcinoma Cell Metastasis.

RNF115 promotes lung adenocarcinoma through Wnt/β-catenin pathway activation by mediating APC ubiquitination

DCAF1 interacts with PARD3 to promote hepatocellular carcinoma progression and metastasis by activating the Akt signaling pathway

p53 exerts anticancer effects by regulating enhancer formation and activity

CRL4-DCAF8L1 Regulates BRCA1 and BARD1 Protein Stability

Ubiquitin-specific protease 54 regulates GLUT1-mediated aerobic glycolysis to inhibit lung adenocarcinoma progression by modifying p53 degradation

CRL2-KLHDC3 E3 ubiquitin ligase complex suppresses ferroptosis through promoting p14ARF degradation

CDT1, transcriptionally regulated by E2F2, promotes lung adenocarcinoma progression

CRL2-KLHDC3 E3 ubiquitin ligase complex suppresses ferroptosis through promoting p14 ARF degradation

NCBP1 promotes the development of lung adenocarcinoma through up-regulation of CUL4B.